Comprehensive review on molecular mechanisms of neuropathic pain

Authors

  • Abhilasha Ahlawat Department of Pharmacology, Department of pharmaceutical Education & Research, South Campus, BPS Mahila Vishvavidayalya, Sonipat (Haryana) India

DOI:

https://doi.org/10.56511/JIPBS.2017.v4.i03.pp87-96

Abstract

Neuropathic pain is caused by functional abnormalities of structural lesions in the peripheral or central nervous system. Various diseases, such as postherpetic neuralgia, trigeminal neuralgia, diabetic neuropathy, spinal cord injury, cancer, stroke, and degenerative neurological diseases are responsible for producing neuropathic pain. Its symptoms include spontaneous and stimulus evoked painful sensations such as mechanical hyperalgesia, thermal and cold allodynia. Several maladaptive mechanisms underlying these symptoms have been identified in recent years which include peripheral sensitization of nociception, abnormal excitability of afferent neurons, central sensitization comprising pronociceptive facilitation, dis-inhibition of nociception, central reorganization processes, alterations in various ion channels. This review focuses on these pathophysiological principles, focussing on specific cellular and molecular changes that affect membrane excitability and are responsible for neuropathic pain.

Keywords:

Neuropathic pain, synaptic plasticity, glia, ion channels

Downloads

Download data is not yet available.

References

Vadivelu N, Whitney CJ, Sinatra RS: Pain pathways and acute pain processing. Acute pain management 2009; 3-20.

Ru-Rong J, Berta T, Nedergaard M: Glia and pain: Is chronic pain a gliopathy?. Pain 2013; 154:S10-S28.

James CN, Meyer RA: Mechanisms of neuropathic pain. Neuron 2006; 52.1:77-92.

Freeman R: Not all neuropathy in diabetes is of diabetic etiology: differential diagnosis of diabetic neuropathy. Current Diabetes Reports 2009; 9:423 – 431.

Hansson P, Backonja M, Bouhassira D: Usefulness and limitations of quantitative sensory testing: clinical and research application in neuropathic pain states. Pain 2007; 129:256 – 259.

van Hecke O , Austin SK , Khan RA , Smith BH , Torrance N : Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 2014;155(4):654-62.

Scadding J, Koltzenburg M: Neuropathic pain. Advances in Clinical Neuroscience & Rehabilitation 2003; 3:8-14.

Roland S: Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Current Rheumatology Reports 2002; 4.4:299-305.

Basbaum AI, Bautista DM, Scherrer G, Julius D: Cellular and molecular mechanisms of pain. Cell 2009; 139:267 – 84.

Nitzan-Luques A, Devor M, Tal M: Genotype-selective phenotypic switch in primary afferent neurons contributes to neuropathic pain. Pain 2011; 152:2413 – 2426.

Zhuo M: Neuronal mechanism for neuropathic pain. Molecular Pain 2007; 3:14.

D’Mello R, Marchand F, Pezet S, McMahon SB, Dickenson AH: Perturbing PSD-95 interactions with NR2B-subtype receptors attenuates spinal nociceptive plasticity and neuropathic pain. Molecular Therapeutics 2011; 19:1780 – 1792.

Hu HJ, Gereau RW: Metabotropic glutamate receptor 5 regulates excitability and Kv4.2-containing K channels primarily in excitatory neurons of the spinal dorsal horn. Journal of Neurophysiology 2011; 105:3010 – 3021.

Alvarez FJ, Villalba RM, Carr PA, Grandes P, Somohano PM: Differential distribution of metabotropic glutamate receptors 1a, 1b, and 5 in the rat spinal cord. Journal of Comparative Neurology 2010; 422:464 – 487.

Khasabov SG, Rogers SD, Ghilardi JR, Peters CM, Mantyh PW, Simone DA: Spinal neurons that possess the substance P receptor are required for the development of central sensitization. Journal of Neuroscience 2002; 22:9086 – 9098.

Henry JL: Effects of substance P on functionally identified units in cat spinal cord. Brain Research 1976; 114:439 – 451.

Sun RQ, Tu YJ, Lawand NB, Yan JY, Lin Q, Willis WD: Calcitonin gene-related peptide receptor activation produces PKAand PKCdependent mechanical hyperalgesia and central sensitization. Journal of Neurophysiology 2004; 92:2859 – 2866.

Goadsby PJ: Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends in Molecular Medicine 2007; 13:39 – 44.

Thompson SW, Bennett DL, Kerr BJ, Bradbury EJ, McMahon SB: Brainderived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proceedings of National Academy of Sciences of USA 1999; 96:7714 – 7718.

Slack SE, Pezet S, McMahon SB, Thompson SW, Malcangio M: Brainderived neurotrophic factor induces NMDA receptor subunit one phosphorylation via ERK and PKC in the rat spinal cord. European Journal of Neuroscience 2004; 20:1769 – 1778.

Kohno T, Wang H, Amaya F, Brenner GJ, Cheng JK, Ji RR, Woolf CJ: Bradykinin enhances AMPA and NMDA receptor activity in spinal cord dorsal horn neurons by activating multiple kinases to produce pain hypersensitivity. Journal of Neuroscience 2008; 28:4533 – 4540.

Wu J, Fang L, Lin Q, Willis WD: Nitric oxide synthase in spinal cord central sensitization following intradermal injection of capsaicin. Pain 2001; 94:47 – 58.

Ding JD, Weinberg RJ: Localization of soluble guanylylcyclase in the superficial dorsal horn. Journal of Comparative Neurology 2006; 495:668 – 678.

Li XY, Ko HG, Chen T, Descalzi G, Koga K, Wang H, Zhuo M: Alleviating neuropathic pain hypersensitivity by inhibiting PKM δ in the anterior cingulate cortex. Science 2010; 330(6009):1400-1404.

Ren W, Palazzo E, Maione S, Neugebauer V: Differential effects of mGluR7 and mGluR8 activation on pain-related synaptic activity in the amygdala. Neuropharmacology 2011; 61:1334 – 1344.

Latremoliere A, Woolf CJ: Central sensitization: a generator of pain hypersensitivity by central neural plasticity. Journal of Pain 2009; 10:895 – 926.

Woolf CJ, Salter, MW: Neuronal plasticity: increasing the gain in pain. Science 2000; 288:1765-1769.

Sandkuhler J: Understanding LTP in pain pathways. Molecular Pain 2007; 3: 9.

Wang CC, Shyu BC: Differential projections from the mediodorsal and centrolateral thalamic nuclei to the frontal cortex in rats. Brain Research 2004; 995(2):226-235.

Liauw J, Wu LJ, Zhuo M: Calcium-stimulated adenylyl cyclases required for long-term potentiation in the anterior cingulate cortex. Journal of Neurophysiology 2005; 94:878-882.

Toyoda H, Zhao MG, Zhuo M: Roles of NMDA receptor NR2A and NR2B subtypes for long-term depression in the anterior cingulate cortex. European Journal of Neuroscience 2005; 22:485-494.

Xu H, Wu LJ, Wang H, Zhang X, Vadakkan KI, Kim SS, Steenland HW, Zhuo M: Presynaptic and postsynaptic amplifications of neuropathic pain in the anterior cingulate cortex. Journal of Neuroscience 2008; 28:74457453.

Melzack R, Wall PD: Pain mechanisms: a new theory. Science 1965; 150:971 – 979.

Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ: Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. Journal of Neuroscience 2002; 22(15):6724-6731.

Stiller CO, Cui JG, O'Connor WT, Brodin E, Meyerson BA, Linderoth B: Release of γ -aminobutyric acid in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats. Neurosurgery 1996; 39(2):367-375.

Castro-Lopes JM, Malcangio M, Pan BH, Bowery NG: Complex changes of GABAA and GABAB receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy. Brain Research, 2006; 679:289 – 97.

Scholz J, Broom DC, Youn DH, et al. Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. Journal of Neuroscience, 2005; 25:7317 – 23.

Coull JA, Boudreau D, Bachand K, Prescott SA, Nault F, Sik A, De Koninck P, De Koninck Y: Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 2003; 424:938-942.

Zhang W, Liu LY, Xu TL: Reduced potassium-chloride co-transporter expression in spinal cord dorsal horn neurons contributes to inflammatory pain hypersensitivity in rats. Neuroscience 2008; 152:502-510.

Knabl J, Witschi R, Hösl K, Reinold H, Zeilhofer UB, Ahmadi S, Zeilhofer HU: Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature 2008; 451(7176):330-334.

Harvey RJ, Depner UB, Wassle H, Ahmadi S, Heindl C, Reinold H, Smart TG, Harvey K, Schutz B, Abo-Salem OM, Zimmer A, Poisbeau P, Welzl H, Wolfer DP, Betz H, Zeilhofer HU, Muller U: GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science 2004; 304:884 – 7.

Koerber HR, Mirnics K, Brown PB, Mendell LM: Central sprouting and functional plasticity of regenerated primary afferents. Journal of Neuroscience 1994; 14:3655 – 71.

Woolf CJ, Shortland P, Coggeshall RE: Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature, 1992; 355:75 – 8.

Tony L, Linda YS, Sorkin: Mechanisms of neuropathic pain. Current Medicinal Chemistry 2005; 5:129-140.

DeLeo JA, Sorkin LS, Watkins LR, editors: Immune and Glial Regulation of Pain, 2007.

Wu LJ, Zhuo M: Resting microglial motility is independent of synaptic plasticity in mammalian brain. Journal of Neurophysiology 2008; 99:2026-2032.

Maeda M, Tsuda M, Tozaki-Saitoh H, Inoue K, Kiyama H: Nerve injuryactivated microglia engulf myelinated axons in a P2Y12 signalingdependent manner in the dorsal horn. Glia 2010; 58:1838 – 1846.

Inoue K, Tsuda M: The role of microglia and ATP receptors in a mechanism of neuropathic pain. Nippon Yakurigaku Zasshi 2006;127:14 – 17.

Kobayashi K, Yamanaka H, Fukuoka T, Dai Y, Obata K, Noguchi K: P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. Journal of Neuroscience 2008; 28:2892 – 2902.

Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y: BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005; 438:1017 – 1021.

Obata K, Katsura H, Miyoshi K, Kondo T, Yamanaka H, Kobayashi K, Noguchi K: Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. Journal of Neurochemistry 2008; 105(6): 2249-2259.

Lindia JA, McGowan E, Jochnowitz N, Abbadie C: Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. Journal of Pain 2005; 6:434-438.

Obata K, Katsura H, Mizushima T, Sakurai J, Kobayashi K, Yamanaka H, Dai Y, Fukuoka T, Noguchi K: Roles of extracellular signal-regulated protein kinases 5 in spinal microglia and primary sensory neurons for neuropathic pain. Journal of Neurochemistry 2007; 102:1569 – 84.

Ji RR, Gereau RW, Malcangio M, Strichartz GR: MAP kinase and pain. Brain Research Reviews 2009; 60;135 – 48.

Jin SX, Zhuang ZY, Woolf CJ, Ji RR: P38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. Journal of Neuroscience 2003; 23: 4017 – 22.

Gao YJ, Xu ZZ, Liu YC, Wen YR, Decosterd I, Ji RR: The c-Jun Nterminal kinase 1 (JNK1) in spinal astrocytes is required for the maintenance of bilateral mechanical allodynia under a persistent inflammatory pain condition. Pain 2010; 148:309 – 19.

Zhuang Z, Gerner P, Woolf CJ, Ji RR: ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005; 114:149 – 59.

Zhang L, Berta T, Xu ZZ, Liu T, Park JY, Ji RR: TNF-alpha contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2. Pain 2011; 152:419 – 27.

Clark AK, Staniland AA, Marchand F, Kaan TK, McMahon SB, Malcangio M: P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide. Journal of Neuroscience 2010; 30:573 – 82.

Chu YX, Zhang YQ, Zhao ZQ: Involvement of microglia and interleukin18 in the induction of long-term potentiation of spinal nociceptive responses induced by tetanic sciatic stimulation. Neuroscience Bulletin 2012; 28:49 – 60.

Ulmann L, Hatcher JP, Hughes JP, Chaumont S, Green PJ, Conquet F, Buell GN, Reeve AJ, Chessell IP, Rassendren F: Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. Journal of Neuroscience 2008; 28:11263 – 8.

Ji RR, Kawasaki Y, Zhuang ZY, Wen YR, Decosterd I: Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biology 2006; 2:259 – 69.

Kozai T, Yamanaka H, Dai Y, Obata K, Kobayashi K, Mashimo T, Noguchi K: Tissue type plasminogen activator induced in rat dorsal horn astrocytes contributes to mechanical hypersensitivity following dorsal root injury. Glia 2007; 55:595 – 603.

Negri L, Maftei D: Targeting the Prokineticin System to Control Chronic Pain and Inflammation. Current medicinal chemistry, 2017.

Bardoni R, Ghirri A, Zonta M, Betelli C, Vitale G, Ruggieri V, Sandrini M, Carmignoto G: Glutamate-mediated astrocyte-to-neuron signalling in the rat dorsal horn. Journal of Physiology 2010; 588:831 – 46.

Kawasaki Y, Zhang L, Cheng JK, Ji RR: Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. Journal of Neuroscience 2008; 28:5189 – 94.

Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodriguez JJ, Nedergaard M: Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro 2012; 4.

Nickel FT, Seifert F, Lanz S, Maihöfner C: Mechanisms of neuropathic pain. European Neuropsychopharmacology 2012; 22: 81 – 91.

Bridges D, Thompson SWN, Rice ASC: Mechanisms of neuropathic pain. British Journal of Anaesthesia 2001; 87.1:12-26.

Amir R, Kocsis JD, Devor M: Multiple interacting sites of ectopic spike electrogenesis in primary sensory neurons. Journal of Neuroscience 2005; 25:2576 – 2585.

Amir R, Michaelis M, Devor M: Membrane potential oscillations in dorsal root ganglion neurons: role in normal electrogenesis and neuropathic pain. Journal of Neuroscience 1999; 19:8589 – 8596.

Cummins TR, Sheets PL, Waxman SG: The roles of sodium channels in nociception: Implications for mechanisms of pain. Pain 2007; 131:243 – 257.

Wang W, Gu J, Li YQ, Tao YX Are voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain. Molecular Pain 2011; 7:16.

Woolf CJ, Mannion RJ: Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet1999; 353:1959 – 1964.

Fukuoka T, Kobayashi K, Yamanaka H, Obata K, Dai Y, Noguchi K. Comparative study of the distribution of the alpha-subunits of voltagegated sodium channels in normal and axotomized rat dorsal root ganglion neurons. Journal of Comparative Neurology 2008; 510:188 – 206.

Fukuoka T, Noguchi K: Comparative study of voltage-gated sodium channel alpha-subunits in nonoverlapping four neuronal populations in the rat dorsal root ganglion. Neuroscience Research 2011; 70:164 – 171.

Khasar SG, Lin YH, Martin A, Dadgar J, McMahon T, Wang D, Hundle B, Aley KO, Isenberg W, McCarter G, Green PG, Hodge CW, Levine JD, Messing RO: A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron 1999; 24:253 – 260.

Cummins TR, Black JA, Dib-Hajj SD, Waxman SG: Glial-derived neurotrophic factor upregulates expression of functional SNS and NaN sodium channels and their currents in axotomized dorsal root ganglion neurons. Journal of Neuroscience 2000; 20:8754-8761.

He XH, Zang Y, Chen X, Pang RP, Xu JT, Zhou X, Wei XH, Li YY, Xin WJ, Qin ZH, Liu XG: TNF-alpha contributes to up-regulation of Nav1.3 and Nav1.8 in DRG neurons following motor fiber injury. Pain 2010; 151:266-279.

Stamboulian S, Choi JS, Ahn HS, Chang YW, Tyrrell L, Black JA, Waxman SG, Dib-Hajj SD: ERK1/2 mitogen-activated protein kinase phosphorylates sodium channel Na(v)1.7 and alters its gating properties. Journal of Neuroscience 2010; 30:1637-1647.

Kim DS, Choi JO, Rim HD, Cho HJ: Downregulation of voltage-gated potassium channel alpha gene expression in dorsal root ganglia following chronic constriction injury of the rat sciatic nerve. Brain Research 2002b; 105:146 – 152.

Rose K, Ooi L, Dalle C, Robertson B, Wood IC, Gamper N: Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury. Pain 2011; 152:742 – 754.

Wang H, Woolf CJ: Pain TRPs. Neuron,2005;46:9 – 12.

Hudson LJ, Bevan S, Wotherspoon G, Gentry C, Fox A, Winter J: VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. European Journal of Neuroscience 2001; 13(11):2105-2114.

Watabiki T, Kiso T, Kuramochi T, Yonezawa K, Tsuji N, Kohara A, Kakimoto S, Aoki T, Matsuoka N: Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect. Journal of Pharmacology and Experimental Therapeutics 2011; 336:743 – 750.

Weller K, Reeh PW, Sauer SK: TRPV1, TRPA1, and CB1 in the isolated vagus nerve-Axonal chemosensitivity and control of neuropeptide release. Neuropeptides 2011; 45:391 – 400.

Gaudet AD, Popovich PG, Ramer MS: Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. Journal of Neuroinflammation 2011; 8:110.

Hoffmann T, Sauer SK, Horch RE, Reeh PW: Sensory transduction in peripheral nerve axons elicits ectopic action potentials. Journal of Neuroscience 2008; 28:6281 – 6284.

Obata K, Yamanaka H, Fukuoka T, Yi D, Tokunaga A, Hashimoto N, Noguchi K: Contribution of injured and uninjured dorsal root ganglion neurons to pain behavior and the changes in gene expression following chronic constriction injury of the sciatic nerve in rats. Pain 2003; 101(1):65-77.

Tominaga M, Tominaga T: Structure and function of TRPV1. P flugers Archiv 2005; 45:143-150.

Premkumar LS, Ahern GP: Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000; 408:985-990.

Hu HJ, Bhave G, GereauRWt: Prostaglandin and protein kinase Adependent modulation of vanilloid receptor function by metabotropic glutamate receptor 5: potential mechanism for thermal hyperalgesia. Journal of Neuroscience 2002; 22:7444-7452.

Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, Chao MV, Julius D: Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4, 5) P2mediated inhibition. Nature 2001; 411:957-962.

Danielle P, Luo DZ: Targeting voltage-gated calcium channels for neuropathic pain management. Neurotherapy 2009; 6.4:679-692.

White FA, Bhangoo SK, Miller RJ: Chemokines: integrators of pain and inflammation. Nature Reviews Drug Discovery 2005; 4:834 – 44.

McMahon SB, Cafferty WB, Marchand F: Immune and glial cell factors as pain mediators and modulators. Experimental Neurology 2005; 192: 444 – 62.

Zhang JM, Li H, Liu B, Brull SJ: Acute topical application of tumor necrosis factor α evokes protein kinase A-dependent responses in rat sensory neurons. Journal of Neurophysiology 2002; 88(3):1387-1392.

Published

05-07-2017
Statistics
252 Views | 217 Downloads

How to Cite

Abhilasha Ahlawat. “Comprehensive Review on Molecular Mechanisms of Neuropathic Pain”. Journal of Innovations in Pharmaceutical and Biological Sciences, vol. 4, no. 3, July 2017, pp. 87-96, doi:10.56511/JIPBS.2017.v4.i03.pp87-96.

Issue

Section

Review Article